{"transactions":[{"id":754717,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:30:06.000Z","date":"2026-06-01","kind":"sale","planned":false,"acquired":false,"shares":1177,"price":18.99,"value":22351.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":139252,"source":{"system":"sec-edgar","filing":"0001193125-26-253603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312526253603/ownership.xml","form_type":"4"}},{"id":813980,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-07T12:47:16.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":32751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on April 1, 2027."}],"balance_after":32751,"source":{"system":"sec-edgar","filing":"0001493152-26-015456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226015456/ownership.xml","form_type":"4"}},{"id":911825,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T13:59:55.000Z","date":"2026-02-09","kind":"sale","planned":false,"acquired":false,"shares":3410,"price":21.028,"value":71705.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":140429,"source":{"system":"sec-edgar","filing":"0001193125-26-043813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312526043813/ownership.xml","form_type":"4"}},{"id":915976,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-02-06T22:53:43.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":118000,"price":20.43,"value":2410740.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option shall vest monthly over a four-year period."}],"balance_after":118000,"derivative":{"exercise_price":20.43,"expiration_date":"2036-02-04","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001193125-26-041497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312526041497/ownership.xml","form_type":"4"}},{"id":915975,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:53:43.000Z","date":"2026-02-06","kind":"sale","planned":false,"acquired":false,"shares":2082,"price":20.62,"value":42930.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":143839,"source":{"system":"sec-edgar","filing":"0001193125-26-041497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312526041497/ownership.xml","form_type":"4"}},{"id":915974,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:53:43.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":30750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company."}],"balance_after":145921,"source":{"system":"sec-edgar","filing":"0001193125-26-041497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312526041497/ownership.xml","form_type":"4"}},{"id":915973,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:53:43.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of restricted stock units (\"RSUs\"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested."}],"balance_after":115171,"source":{"system":"sec-edgar","filing":"0001193125-26-041497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312526041497/ownership.xml","form_type":"4"}},{"id":915972,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:53:43.000Z","date":"2026-01-30","kind":"other","planned":false,"acquired":true,"shares":1219,"price":8.48,"value":10337.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,219 shares by the Reporting Person on 1/30/2026 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":93671,"source":{"system":"sec-edgar","filing":"0001193125-26-041497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312526041497/ownership.xml","form_type":"4"}},{"id":985036,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-01T21:30:03.000Z","date":"2025-12-01","kind":"gift","planned":false,"acquired":false,"shares":1224,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92452,"source":{"system":"sec-edgar","filing":"0001193125-25-303941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000119312525303941/ownership.xml","form_type":"4"}},{"id":1072200,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-07T21:30:22.000Z","date":"2025-07-31","kind":"other","planned":false,"acquired":true,"shares":1226,"price":8.43,"value":10335.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,226 shares by the Reporting Person on 07/31/2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":93676,"source":{"system":"sec-edgar","filing":"0000950170-25-105258","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000095017025105258/ownership.xml","form_type":"4"}},{"id":1084664,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-18T20:30:06.000Z","date":"2025-07-16","kind":"sale","planned":false,"acquired":false,"shares":1296,"price":9.285,"value":12033.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":92450,"source":{"system":"sec-edgar","filing":"0000950170-25-096948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000095017025096948/ownership.xml","form_type":"4"}},{"id":1142603,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T20:04:07.000Z","date":"2025-05-19","kind":"purchase","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase prices ranged from $8.8465 to $9.2825."}],"balance_after":93746,"source":{"system":"sec-edgar","filing":"0000950170-25-074304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000095017025074304/ownership.xml","form_type":"4"}},{"id":1271622,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:16:46.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":3777,"price":15.504,"value":58558.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":90746,"source":{"system":"sec-edgar","filing":"0000950170-25-019005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000095017025019005/ownership.xml","form_type":"4"}},{"id":1278688,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-02-07T21:44:26.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":110500,"price":14.65,"value":1618825.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option shall vest monthly over a four-year period."}],"balance_after":110500,"derivative":{"exercise_price":14.65,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":110500},"source":{"system":"sec-edgar","filing":"0000950170-25-016389","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000095017025016389/ownership.xml","form_type":"4"}},{"id":1278687,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-07T21:44:26.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":23400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company."}],"balance_after":94523,"source":{"system":"sec-edgar","filing":"0000950170-25-016389","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000095017025016389/ownership.xml","form_type":"4"}},{"id":1278686,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-07T21:44:26.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units (\"RSUs\"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested."}],"balance_after":71123,"source":{"system":"sec-edgar","filing":"0000950170-25-016389","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000095017025016389/ownership.xml","form_type":"4"}},{"id":1477281,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-17T13:26:27.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":1250,"price":20.0298,"value":25037.25,"ownership":{"direct":true},"balance_after":52623,"source":{"system":"sec-edgar","filing":"0001562180-24-005118","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218024005118/primarydocument.xml","form_type":"4"}},{"id":1651560,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-09T21:05:02.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":22.28,"value":1559600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option shall vest monthly over a four-year period."}],"balance_after":70000,"derivative":{"exercise_price":22.28,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001562180-24-001222","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218024001222/primarydocument.xml","form_type":"4"}},{"id":1651559,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-09T21:05:02.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company."}],"balance_after":51373,"source":{"system":"sec-edgar","filing":"0001562180-24-001222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218024001222/primarydocument.xml","form_type":"4"}},{"id":1651558,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-09T21:05:02.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Award of restricted stock units (\"RSUs\"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested."}],"balance_after":39673,"source":{"system":"sec-edgar","filing":"0001562180-24-001222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218024001222/primarydocument.xml","form_type":"4"}},{"id":1651557,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-09T21:05:02.000Z","date":"2024-01-31","kind":"other","planned":false,"acquired":true,"shares":1183,"price":17.42,"value":20607.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,183 shares by the Reporting Person on 01/31/2024 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":4673,"source":{"system":"sec-edgar","filing":"0001562180-24-001222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218024001222/primarydocument.xml","form_type":"4"}},{"id":1651556,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-09T21:05:02.000Z","date":"2023-07-31","kind":"other","planned":false,"acquired":true,"shares":862,"price":18.12,"value":15619.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 862 shares by the Reporting Person on 07/31/2023 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":3490,"source":{"system":"sec-edgar","filing":"0001562180-24-001222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218024001222/primarydocument.xml","form_type":"4"}},{"id":1855873,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-14T20:20:09.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":577,"price":22.31,"value":12872.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":2628,"source":{"system":"sec-edgar","filing":"0001562180-23-005152","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218023005152/primarydocument.xml","form_type":"4"}},{"id":2032931,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-02-03T22:00:34.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":110000,"price":28.55,"value":3140500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest monthly over a four-year period."}],"balance_after":110000,"derivative":{"exercise_price":28.55,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001562180-23-000953","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218023000953/primarydocument.xml","form_type":"4"}},{"id":2231454,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-06-15T20:12:27.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":230000,"price":15.6,"value":3588000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty five percent (25%) of the total number of shares underlying the option shall vest on June 13, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates."}],"balance_after":230000,"derivative":{"exercise_price":15.6,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001562180-22-005117","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218022005117/primarydocument.xml","form_type":"4"}},{"id":2231453,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-15T20:12:27.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":3205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units that vest 50% of the shares on June 13, 2023 and the remaining 50% of the shares on June 13, 2024."}],"balance_after":3205,"source":{"system":"sec-edgar","filing":"0001562180-22-005117","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000156218022005117/primarydocument.xml","form_type":"4"}},{"id":2327359,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-17T17:23:49.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":4617,"price":2.11,"value":9741.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":141726,"source":{"system":"sec-edgar","filing":"0001494650-22-000029","document":"wf-form4_164753781398908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465022000029/wf-form4_164753781398908.xml","form_type":"4"}},{"id":2436824,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T21:02:39.000Z","date":"2022-01-11","kind":"grant","acquired":true,"shares":66185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the maximum number of options eligible to vest during the 4-year vesting period subject to the achievement of certain performance-based objectives relating to the trading price of OptiNose, Inc. common stock.  If the minimum performance criteria relating to the trading price of OptiNose, Inc. common stock is not achieved, then none of the options will be eligible to vest."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable over a four-year period, commencing on January 11, 2022, subject to the achievement of certain performance-based objectives relating to the trading price of OptiNose, Inc. common stock and continued service with the Issuer."}],"balance_after":66185,"derivative":{"exercise_price":1.85,"expiration_date":"2026-01-11","underlying":"Common Stock","underlying_shares":66185},"source":{"system":"sec-edgar","filing":"0001494650-22-000006","document":"wf-form4_164202134380026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465022000006/wf-form4_164202134380026.xml","form_type":"4"}},{"id":2436823,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T21:02:39.000Z","date":"2022-01-11","kind":"grant","acquired":true,"shares":85095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable over a four-year period commencing on January 11, 2022. Twenty-five percent (25%) of the option vests and becomes exercisable on January 11, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":85095,"derivative":{"exercise_price":1.85,"expiration_date":"2032-01-11","underlying":"Common Stock","underlying_shares":85095},"source":{"system":"sec-edgar","filing":"0001494650-22-000006","document":"wf-form4_164202134380026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465022000006/wf-form4_164202134380026.xml","form_type":"4"}},{"id":2436822,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:02:39.000Z","date":"2022-01-11","kind":"grant","acquired":true,"shares":56730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). Twenty-five percent (25%) of the RSUs vest on January 11, 2023, and the balance vests in equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of OptiNose, Inc."}],"balance_after":146343,"source":{"system":"sec-edgar","filing":"0001494650-22-000006","document":"wf-form4_164202134380026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465022000006/wf-form4_164202134380026.xml","form_type":"4"}},{"id":2466035,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-17T14:27:20.000Z","date":"2021-12-16","kind":"sale","acquired":false,"shares":580,"price":1.64,"value":951.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":89613,"source":{"system":"sec-edgar","filing":"0001494650-21-000155","document":"wf-form4_163975122697686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000155/wf-form4_163975122697686.xml","form_type":"4"}},{"id":2565740,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-17T17:53:00.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":578,"price":2.789,"value":1612.042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":90193,"source":{"system":"sec-edgar","filing":"0001494650-21-000108","document":"wf-form4_163190116827344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000108/wf-form4_163190116827344.xml","form_type":"4"}},{"id":2663735,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-17T22:35:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":576,"price":3.73,"value":2148.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":90771,"source":{"system":"sec-edgar","filing":"0001494650-21-000076","document":"wf-form4_162396931494948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000076/wf-form4_162396931494948.xml","form_type":"4"}},{"id":2782309,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-17T22:11:45.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":2304,"price":3.92,"value":9031.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":91347,"source":{"system":"sec-edgar","filing":"0001494650-21-000041","document":"wf-form4_161601907384985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000041/wf-form4_161601907384985.xml","form_type":"4"}},{"id":2782302,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T22:04:16.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":45850,"price":5.41,"value":248048.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable over a four-year period commencing on March 6, 2020. Twenty-five percent (25%) of the option vests and becomes exercisable on March 6, 2021, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":45850,"derivative":{"exercise_price":5.41,"expiration_date":"2030-03-06","underlying":"Common Stock","underlying_shares":45850},"source":{"system":"sec-edgar","filing":"0001494650-21-000032","document":"wf-form4a_161601863167747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000032/wf-form4a_161601863167747.xml","form_type":"4/A","original_submission_date":"2020-03-09"}},{"id":2782301,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-17T22:04:16.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":30567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). Twenty-five percent (25%) of the RSUs vest on March 15, 2021, and the balance vests in equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of OptiNose, Inc."}],"balance_after":37328,"source":{"system":"sec-edgar","filing":"0001494650-21-000032","document":"wf-form4a_161601863167747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000032/wf-form4a_161601863167747.xml","form_type":"4/A","original_submission_date":"2020-03-09"}},{"id":2803172,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-08T22:19:07.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":80000,"price":3.51,"value":280800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable over a four-year period commencing on March 4, 2021. Twenty-five percent (25%) of the option vests and becomes exercisable on March 4, 2022, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":80000,"derivative":{"exercise_price":3.51,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001494650-21-000018","document":"wf-form4_161524193371157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000018/wf-form4_161524193371157.xml","form_type":"4"}},{"id":2803171,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:19:07.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":53333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). Twenty-five percent (25%) of the RSUs vest on March 15, 2022, and the balance vests in equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of OptiNose, Inc."}],"balance_after":63084,"source":{"system":"sec-edgar","filing":"0001494650-21-000018","document":"wf-form4_161524193371157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465021000018/wf-form4_161524193371157.xml","form_type":"4"}},{"id":3023758,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-23T20:47:47.000Z","date":"2020-09-23","kind":"purchase","acquired":true,"shares":2500,"price":3.897,"value":9742.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 490 shares acquired under the Company's employee stock purchase plan on June 30, 2020 at a per share purchase price of $7.34."}],"balance_after":9751,"source":{"system":"sec-edgar","filing":"0001494650-20-000125","document":"wf-form4_160089405254597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465020000125/wf-form4_160089405254597.xml","form_type":"4"}},{"id":3220446,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-09T11:06:11.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":30567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (RSU) represents the right to receive one share of common stock of OptiNose, Inc. Twenty-five percent (25%) of the RSUs vest on March 6, 2021, and the balance vests in equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (RSU) represents the right to receive one share of common stock of OptiNose, Inc. Twenty-five percent (25%) of the RSUs vest on March 6, 2021, and the balance vests in equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":30567,"derivative":{"exercise_price":5.41,"underlying":"Common Stock","underlying_shares":30567},"source":{"system":"sec-edgar","filing":"0001494650-20-000031","document":"wf-form4_158375195126807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465020000031/wf-form4_158375195126807.xml","form_type":"4"}},{"id":3220445,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-09T11:06:11.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":45850,"price":5.41,"value":248048.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period commencing on March 6, 2020. Twenty-five percent (25%) of the option vests and becomes exercisable on March 6, 2021, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":45850,"derivative":{"exercise_price":5.41,"expiration_date":"2030-03-06","underlying":"Common Stock","underlying_shares":45850},"source":{"system":"sec-edgar","filing":"0001494650-20-000031","document":"wf-form4_158375195126807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465020000031/wf-form4_158375195126807.xml","form_type":"4"}},{"id":3309601,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-16T21:11:18.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":2695,"price":6.13,"value":16520.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under the Optinose, Inc. 2017 Employee Stock Purchase Plan on December 31, 2019 in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":6761,"source":{"system":"sec-edgar","filing":"0001494650-20-000002","document":"wf-form5_157920905942139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465020000002/wf-form5_157920905942139.xml","form_type":"5"}},{"id":3465224,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-09T11:30:13.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":941,"price":5.64,"value":5307.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under the OptiNose, Inc. 2017 Employee Stock Purchase Plan on June 28, 2019 in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4066,"source":{"system":"sec-edgar","filing":"0001494650-19-000067","document":"wf-form4_156267179853617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465019000067/wf-form4_156267179853617.xml","form_type":"4"}},{"id":3608386,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-06T23:27:26.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period commencing on February 28, 2019. Twenty-five percent (25%) of the option vests and becomes exercisable on February 28, 2020, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":82500,"derivative":{"exercise_price":7.42,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001494650-19-000027","document":"wf-form4_155191483222043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465019000027/wf-form4_155191483222043.xml","form_type":"4"}},{"id":3700268,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-08T21:54:03.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":3125,"price":13.6,"value":42500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under the Optinose, Inc. 2017 Employee Stock Purchase Plan on June 29, 2018 in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001494650-19-000010","document":"wf-form5_154698442574019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000149465019000010/wf-form5_154698442574019.xml","form_type":"5"}},{"id":4185756,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":42383,"kind":"person","name":"Goldan Keith A.","position":1,"cik":"0001495411","reported_name":"Goldan Keith A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-16T16:41:00.000Z","date":"2017-10-12","kind":"grant","acquired":true,"shares":72197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period commencing on October 12, 2017. Twenty-five percent (25%) of the option vests and becomes exercisable on October 12, 2018, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":72197,"derivative":{"exercise_price":16,"expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":72197},"source":{"system":"sec-edgar","filing":"0001104659-17-062326","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495411/000110465917062326/a4.xml","form_type":"4"}}]}